AAPL
53
4
NEE
33
3
SHW
45
3
NVDA
71
-2
SWN
42
-4
NOC
38
3
TJX
53
2
DOW
20
-10
AN
57
2
AMG
44
3
SWKS
51
5
SJM
51
-2
MUR
42
3
RF
51
4
MHK
24
3
HRL
15
-11
PSX
52
-2
LNC
43
4
NRG
39
-5
NWS
60
5
AAPL
53
4
NEE
33
3
SHW
45
3
NVDA
71
-2
SWN
42
-4
NOC
38
3
TJX
53
2
DOW
20
-10
AN
57
2
AMG
44
3
SWKS
51
5
SJM
51
-2
MUR
42
3
RF
51
4
MHK
24
3
HRL
15
-11
PSX
52
-2
LNC
43
4
NRG
39
-5
NWS
60
5
Financhill
Back

TransMedics Group 10K Form

Buy
56

TMDX
TransMedics Group

Last Price:
70.87
Seasonality Move:
26.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TMDX News And Ratings

See the #1 stock for the next 7 days that we like better than TMDX

TMDX Financial Statistics

Sales & Book Value

Annual Sales: $93.46M
Cash Flow: $-9.59M
Price / Cash Flow: 0
Annual Sales: $5.92
Price / Book: 11.94

Profitability

EPS (TTM): -0.95000
Net Income (TTM): $-28.31M
Gross Margin: $65.27M
Return on Equity: -20.85%
Return on Assets: -13.1%

TransMedics Group Earnings Forecast

Key TransMedics Group Financial Ratios

  • The Gross Profit Margin over the past 7 years for TMDX is 69.84%.
  • The Selling, General & Administrative Expenses for TMDX have been equal to 74.79% of Gross Profit Margin.
  • The Research & Development expenses have been 28.69% of Revenue.
  • The Interest Expense is -10.30% of Operating Income.
  • The Net Earning history of TMDX is -38.77% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

TransMedics Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical Devices
Sector: Healthcare
Current Symbol: TMDX
CUSIP: 89377M
Website: transmedics.com

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 9.14
Quick Ratio: 8.17

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 946.06

TMDX Technical Analysis vs Fundamental Analysis

Buy
56
TransMedics Group (TMDX) is a Buy

Is TransMedics Group a Buy or a Sell?

  • TransMedics Group stock is rated a Buy
    The current TransMedics Group [TMDX] share price is $70.68. The Score for TMDX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.